跳至主要内容
临床试验/NCT02612064
NCT02612064已完成不适用

A Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity

GlaxoSmithKline3 个研究点 分布在 1 个国家目标入组 488 人开始时间: 2015年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
488
试验地点
3
主要终点
Change From Baseline in Schiff Sensitivity Score on Day 3

研究概览

简要总结

This single centre, dual site, comparative design study will be used to investigate the efficacy of an experimental stannous fluoride containing dentifrice in relieving dentinal hypersensitivity (DH) after short term use

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Demonstrates understanding of the study procedures, restrictions and willingness to participate as evidenced by voluntary written informed consent and has received a signed and dated copy of the informed consent form
  • Good general and mental health with, in the opinion of the investigator or medically qualified designee:
  • A. No clinically significant and relevant abnormalities in medical history or upon oral examination.
  • B. Absence of any condition that would impact on the participant's safety or wellbeing or affect the individual's ability to understand and follow study procedures and requirements.
  • Dental health
  • At Screening:
  • A. Self-reported history of dentinal hypersensitivity (DH) lasting more than six months but not more than 10 years.
  • B. Good general oral health, with a minimum of 20 natural teeth.
  • C. Minimum of 2 accessible non-adjacent teeth (incisors, canines, pre-molars), preferably in different quadrants, that meet all of the following criteria:
  • Signs of facial/cervical gingival recession and/or signs of erosion or abrasion (EAR).
  • Tooth with modified gingival index (MGI) score =0 adjacent to the test area (exposed dentine) only and a clinical mobility of ≤
  • Tooth with signs of sensitivity measured by qualifying evaporative air assessment (Y/N response).
  • At Baseline:
  • D. Minimum of two, non-adjacent accessible teeth (incisors, canines, pre-molars), that meet all of the following criteria:
  • Tooth with signs of sensitivity, measured by qualifying tactile stimulus (Yeaple ≤ 20g) and evaporative air assessment (Schiff Sensitivity Score ≥ 2)

排除标准

  • Pregnant or breast feeding women
  • Daily doses of medication/treatments which, in the opinion of the investigator, could interfere with the perception of pain.
  • Currently taking antibiotics or has taken antibiotics within two weeks of Baseline.
  • Daily dose of a medication which, in the opinion of the investigator, is causing xerostomia. - Presence of chronic debilitating disease which, in the opinion of the investigator, could affect study outcomes.
  • Any condition which, in the opinion of the investigator, causes xerostomia.
  • Known or suspected intolerance or hypersensitivity to the study materials (or closely related compounds) or any of their stated ingredients
  • Participation in another clinical study (including cosmetic studies) or receipt of an investigational drug within 30 days of the screening visit.
  • Recent history (within the last year) of alcohol or other substance abuse
  • Dental prophylaxis within four weeks of Screening.
  • Tongue or lip piercing or presence of dental implants.
  • Desensitizing treatment within eight weeks of Screening (professional sensitivity treatments and non-toothpaste sensitivity treatments).
  • Gross periodontal disease, treatment of periodontal disease (including surgery) within 12 months of Screening, scaling or root planning within 3 months of Screening.
  • Teeth bleaching within eight weeks of Screening
  • Tooth with evidence of current or recent caries, or reported treatment of decay within 12 months of Screening.
  • Tooth with exposed dentine but with deep, defective or facial restorations, teeth used as abutments for fixed or removable partial dentures, teeth with full crowns or veneers, orthodontic bands or cracked enamel. Sensitive teeth with contributing aetiologies other than erosion, abrasion or recession of exposed dentine.
  • Sensitive tooth not expected to respond to treatment with an over-the-counter toothpaste in the opinion of the investigator.
  • Use of an oral care product indicated for the relief of dentine hypersensitivity within eight weeks of screening
  • Individuals who require antibiotic prophylaxis for dental procedures

结局指标

主要结局

Change From Baseline in Schiff Sensitivity Score on Day 3

时间窗: Baseline to 3 days

The examiner assessed the participant's response to an evaporative air stimulus for each tooth using the Schiff Sensitivity Scale which was scored as follows - 0: Participant does not respond to air stimulation; 1: Participant responded to air stimulus but does not request discontinuation of stimulus; 2: Participant responded to air stimulus and requests discontinuation or moves from stimulus; 3: Participant responded to stimulus, considered stimulus to be painful, and requested discontinuation of the stimulus. A reduction in Schiff Sensitivity score was indicative of an improvement in sensitivity.

次要结局

  • Change From Baseline in Schiff Sensitivity Score Post First Treatment by Direct Application(Baseline to 60 seconds post first treatment)
  • Change From Baseline in Tactile Threshold Post First Treatment by Direct Application and on Day 3(Baseline, 60 seconds post first treatment, Day 3)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验